CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Receives Speculative Buy Rating, $5 Price Target from Clarus Securities

November 5, 2018 12:30:02

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company headquartered in Markham, Ontario with a Kelowna, British Columbia-based production facility, is making a name for itself in the booming cannabis sector. FLWR was recently covered in a research report by Clarus Securities, which was then highlighted in a recent article published by CantechLetter.com, titled ‘The Flowr Corporation could be a big winner in the cannabis space, Clarus Securities says’. The research report describes the company as “one of the very few Canadian licensed producers of cannabis with experience in successfully scaling indoor cultivation of premium product.” Clarus Securities initiated coverage of FLWR with a “Speculative Buy” rating and one-year price target of $5.00.

“We believe The Flowr Corporation has the potential to be the most successful Canadian cannabis Licensed Producer focused on serving the superpremium product segment,” Clarus Securities analyst Noel Atkinson stated in the report. “The founding production team has decades of collective experience in designing, building and optimizing indoor (or “warehouse”) cultivation projects, most notably for the original MedReleaf facility in Markham, ON (still considered today to be the gold standard for indoor cultivation in Canada). The company has its cultivation and dried flower sales licenses and supply agreements with at least three provinces including B.C. and Ontario, and is expected to ramp revenues substantially in 2020 as it brings its Kelowna, B.C. campus expansions online.”

To view the full article, visit http://cnw.fm/3K4ah

About The Flowr Corporation

Flowr, through its subsidiaries, is a vertically-integrated Canadian cannabis company focused on the natural science of cannabis. With head offices in Markham, ON and production in Kelowna, B.C., Flowr builds and operates large-scale, GMP designed cultivation facilities utilizing their own patented growing systems. Flowr’s investment in research and development ensures that its cultivation team is able to supply patients with consistent, high-quality medicinal cannabis. With a sense of craftsmanship and a spirit of innovation, Flowr is also well positioned with a line of premium quality cannabis products for the upcoming adult-use market. For more information, follow Flowr on Twitter: @FlowrCanada; Facebook: Flowr Canada; and Instagram: @flowrcanada or visit the company’s website at www.Flowr.ca

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com